Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Linda C. van der Knaap"'
Autor:
Stefanie E. M. van Opstal, Emma J. Dogterom, Marlies N. Wagener, Femke K. Aarsen, Harald S. Miedema, Pepijn D. D. M. Roelofs, Linda C. van der Knaap, Pieter L. A. Fraaij, Kim Stol, André B. Rietman, Eric C. M. van Gorp, Annemarie M. C. van Rossum, Elisabeth M. W. J. Utens
Publikováno v:
Viruses, Vol 13, Iss 10, p 1947 (2021)
Advances in antiretroviral treatment improved the life expectancy of perinatally HIV-infected children. However, growing up with HIV provides challenges in daily functioning. This cross-sectional cohort study investigated the neuropsychological and p
Externí odkaz:
https://doaj.org/article/b73f6dc8493c4db28c5387039f834313
Autor:
Annemarie M. C. van Rossum, M.N. Wagener, Harald S. Miedema, Eric C. M. van Gorp, Stefanie E. M. van Opstal, Linda C. van der Knaap, Pepijn D D M Roelofs, Elisabeth M. W. J. Utens, Femke K. Aarsen
Publikováno v:
PLoS ONE, 16 (2021), nr. 6(e0252746). plos.org
PLoS ONE, Vol 16, Iss 6, p e0252746 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 6, p e0252746 (2021)
PLoS ONE
IntroductionSince the introduction of combination antiretroviral therapy, human immunodeficiency virus (HIV) infection is a manageable chronic disease. However, school-age children (4–18 years) living with HIV could still experience problems with f
Autor:
Annemarie M.C. van Rossum, Pieter L.A. Fraaij, Clementien L. Vermont, Linda C. van der Knaap, Kim Stol, Eline G. Visser, Erica Witkamp, Annemieke Hoogenboom
Although fatigue is a common symptom in adult patients with Primary Immunodeficiencies (PID), data in pediatric patients are limited. The goal of this study is to estimate the prevalence and impact of fatigue in children with PID as reported by patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4217fd0ac4e9e366d2470256708c8b68
https://doi.org/10.21203/rs.3.rs-414055/v1
https://doi.org/10.21203/rs.3.rs-414055/v1
Autor:
Ivar P. E. Gondrie, Nico G. Hartwig, Linda C. van der Knaap, Petronette van Jaarsveld, Diane E. T. Bastiaans, Eline G. Visser, Pieter L. A. Fraaij, Annemarie M. C. van Rossum, David M. Burger, Gertjan J. Driessen, Ronald de Groot
Publikováno v:
Pediatric Infectious Disease Journal, 36, 976-980
Pediatric Infectious Disease Journal, 36, 10, pp. 976-980
Pediatric Infectious Disease Journal, 36(10), 976-980. Lippincott Williams & Wilkins
Pediatric Infectious Disease Journal, 36, 10, pp. 976-980
Pediatric Infectious Disease Journal, 36(10), 976-980. Lippincott Williams & Wilkins
Contains fulltext : 176929.pdf (Publisher’s version ) (Closed access) BACKGROUND: The use of lopinavir/ritonavir once-daily (LPV/r QD) has not been approved for children. Good short-term clinical, virologic and immunologic outcomes have been observ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8095f7261efc2e333ec29887d5a4f9a7
http://hdl.handle.net/2066/176929
http://hdl.handle.net/2066/176929
Autor:
P. L. A. Fraaij, F. W. N. M. Wit, Sophie Cohen, W. E. M. Schouten, W. Kortmann, Laura van Zonneveld, J. G. den Hollander, J. V. Smit, Marien H. J. Kuipers-Jansen, F. J. B. Nellen, Jan M Prins, M. P. W. Kastelijns, J. W. Bouwhuis, Kees Brinkman, H. de Jonge, Joke C. Patist, Eline G. Visser, K. Pogány, S. Cohen, N. Nauta, G. J. A. Driessen, Michelle Mutschelknauss, I. B. van der Meche, L. M. van Zonneveld, P. P. Koopmans, J. A. Schippers, Bert J. Zomer, Dasja Pajkrt, I. M. Hoepelman, S. H. Lowe, D. C. Pronk, Peter Reiss, Linda C. van der Knaap, H. J. Scherpbier, A. van der Plas, A. M. C. van Rossum, Charlotte Blokhuis, R. Strik Albers, Frank P. Kroon, Colette Smit, A. M. Weijsenfeld, M.E. van der Ende, Esther P. Smit, S. P. M. Geelen, P. A. van der Meulen, C. Richter, M. H. J. Kuipers-Jansen, Annouschka M. Weijsenfeld, A. E. Brouwer, B. J. Zomer, T. F. W. Wolfs, W. F. W. Bierman, Stefanie S. V. Henriet, G. ter Beest, Ferdinand W. N. M. Wit, J. F. van den Berg, C. Moons, C. Blokhuis, S. Faber, M. van Vonderen, M. Mutschelknauss, Nike Nauta, M. E. Vriesde, M. van der Flier, J. C. Patist, E. H. Gisolf, M.E.E. van Kasteren, Erasmus Smit, C. Smit, T. Mudrikova, L. van der Knaap, E. Oude Geerdink, E. H. Scholvink, N. Y. Bassant, D. Pajkrt
Publikováno v:
Clinical infectious diseases, 63(8), 1105-1112. Oxford University Press
Clinical Infectious Diseases, 63(8), 1105-1112. Oxford University Press
Clinical Infectious Diseases, 63, 8, pp. 1105-12
Clinical Infectious Diseases, 63, 1105-12
Clinical Infectious Diseases, 63(8), 1105. Oxford University Press
Clinical Infectious Diseases, 63(8), 1105-1112. Oxford University Press
Clinical Infectious Diseases, 63, 8, pp. 1105-12
Clinical Infectious Diseases, 63, 1105-12
Clinical Infectious Diseases, 63(8), 1105. Oxford University Press
Item does not contain fulltext BACKGROUND: As a result of effective combination antiretroviral therapy (cART) and advanced supportive healthcare, a growing number of human immunodeficiency virus (HIV)-infected children survive into adulthood. The per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf76a24dc004e38bf47327cc22315dc
https://pure.amc.nl/en/publications/virological-and-social-outcomes-of-hivinfected-adolescents-and-young-adults-in-the-netherlands-before-and-after-transition-to-adult-care(8c484b20-f000-4f60-a6c9-7410e0e8a8a2).html
https://pure.amc.nl/en/publications/virological-and-social-outcomes-of-hivinfected-adolescents-and-young-adults-in-the-netherlands-before-and-after-transition-to-adult-care(8c484b20-f000-4f60-a6c9-7410e0e8a8a2).html
Autor:
David M. Burger, Linda C. van der Knaap, Manon J. van der Lee, Gertjan J. Driessen, Gwenda Verweel, Nico G. Hartwig, Petronette van Jaarsveld, Michiel van der Flier
Publikováno v:
Antiviral Therapy. 13:1087-1090
BackgroundRecently, a new tablet formulation of the widely used HIV protease inhibitor lopinavir/ritonavir was licensed. Here, we present a pilot study of the pharmaco-kinetics of the new adult tablet formulation taken once daily in children.MethodsL
Autor:
S. Jedeloo, Linda C. van der Knaap
Publikováno v:
Sex Education, 15(4), 406-420. Routledge
Young people living with HIV are challenged when it comes to exploring their sexuality. Their sex education is hampered by the fact that their preferences and attitudes towards sexual behaviour are little known about. In this study from the Netherlan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0462362cea36725706e8cc88613ed870
https://pure.eur.nl/en/publications/317d565b-bfe0-4ab6-9a3f-af1fd699d0b1
https://pure.eur.nl/en/publications/317d565b-bfe0-4ab6-9a3f-af1fd699d0b1
Autor:
Michiel, van der Flier, Gwenda, Verweel, Linda C, van der Knaap, Petronette, van Jaarsveld, Gert-Jan, Driessen, Manon, van der Lee, Nico G, Hartwig, David M, Burger
Publikováno v:
Antiviral therapy. 13(8)
Recently, a new tablet formulation of the widely used HIV protease inhibitor lopinavir/ritonavir was licensed. Here, we present a pilot study of the pharmacokinetics of the new adult tablet formulation taken once daily in children.Lopinavir pharmacok
Autor:
Gwenda, Verweel, David M, Burger, Nancy L, Sheehan, Alina S, Bergshoeff, Adilia, Warris, Linda C, van der Knaap, Gertjan, Driessen, Ronald, de Groot, Nico G, Hartwig
Publikováno v:
Antiviral therapy. 12(4)
Lopinavir/ritonavir (LPV/r) has been licensed for the treatment of HIV-infected children6 months in the US and2 years in the EU. Limited LPV paediatric pharmacokinetic data are available. We studied LPV pharmacokinetics to determine whether the recom
Autor:
Ronald de Groot, Nico G. Hartwig, Gwenda Verweel, Adilia Warris, David M. Burger, Alina S. Bergshoeff, Nancy L. Sheehan, Linda C Van Der Knaap, Gertjan J. Driessen
Publikováno v:
Antiviral Therapy, 12, 4, pp. 453-8
Antiviral Therapy, 12, 453-8
Antiviral Therapy, 12(4), 453-458. International Medical Press Ltd
Antiviral Therapy, 12, 453-8
Antiviral Therapy, 12(4), 453-458. International Medical Press Ltd
BackgroundLopinavir/ritonavir (LPV/r) has been licensed for the treatment of HIV-infected children >6 months in the US and >2 years in the EU. Limited LPV paediatric pharmacokinetic data are available. We studied LPV pharmacokinetics to determine whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97e71a89ea29cf6dcb0b31180300c42
https://hdl.handle.net/2066/52704
https://hdl.handle.net/2066/52704